Predictors of relapse after discontinuing antipsychotics in patients with schizophrenia spectrum disorders

We studied 61 patients with schizophrenia spectrum disorders who discontinued medication after achieving symptomatic remission. Over 3 years, relapse rates were significantly higher in those not meeting full recovery (p = 0.006) or remission (p < 0.001) criteria, with rates up to twice as high. Significant differences between relapsed and maintained groups included age at onset (p = 0.004), age at discontinuation (p = 0.009), and proportions meeting full recovery (p = 0.001) or remission (p = 0.003). Univariate Cox regression identified older age of onset (p = 0.038), lack of full recovery (p = 0.008) or remission (p = 0.001), and higher positive symptom score (p = 0.018) as predictors of relapse. In multivariate analysis, only full remission remained significant (p = 0.002). Our findings suggest that in making decision about discontinuation, applying more strict approaches, i.e., full recovery or remission criteria and detailed assessment of positive symptoms are critical and essential.

Authors

Institutions

Publication Details

Journal
Schizophrenia
Published
2025-03-13
DOI
https://doi.org/10.1038/s41537-025-00592-3
Citations
1
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
1.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictors of relapse after discontinuing antipsychotics in patients with schizophrenia spectrum disorders

Young‐Chul Chung, Thuc Duy Le, Woosung Kim, Soyolsaikhan Odkhuu et al.
1 citations
Schizophrenia
Schizophrenia research and treatment
1.47
article

Predictors of relapse after discontinuing antipsychotics in patients with schizophrenia spectrum disorders

Young‐Chul Chung, Thuc Duy Le, Woosung Kim, Soyolsaikhan Odkhuu, Fatima Zahra Rami, Ling Li, Eun‐Jin Jeon, Chae Yeong Kang, Ariana Setiani
article en
1 citations

Abstract

We studied 61 patients with schizophrenia spectrum disorders who discontinued medication after achieving symptomatic remission. Over 3 years, relapse rates were significantly higher in those not meeting full recovery (p = 0.006) or remission (p < 0.001) criteria, with rates up to twice as high. Significant differences between relapsed and maintained groups included age at onset (p = 0.004), age at discontinuation (p = 0.009), and proportions meeting full recovery (p = 0.001) or remission (p = 0.003). Univariate Cox regression identified older age of onset (p = 0.038), lack of full recovery (p = 0.008) or remission (p = 0.001), and higher positive symptom score (p = 0.018) as predictors of relapse. In multivariate analysis, only full remission remained significant (p = 0.002). Our findings suggest that in making decision about discontinuation, applying more strict approaches, i.e., full recovery or remission criteria and detailed assessment of positive symptoms are critical and essential.

SchizophreniaVol. 11(1)
Jeonbuk National University Hospital (KR), Jeju National University Hospital (KR), Jeonbuk National University (KR)
Korea Health Industry Development Institute
Good health and well-being
Openalex Percentile: Top 22%
Schizophrenia research and treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.